NCT05970302
- Conditions
- Bevacizumab, Capecitabine, Colonic Diseases, +16 more
- Locations
-
- Lin Yang Beijing, China
Clinical trial condition
Tislelizumab
Explore clinical trials studying Tislelizumab. Study availability and eligibility vary by location and protocol.
17 public trials
11 recruiting studies
Tislelizumab trial results
Not Yet Recruiting
Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC
NCT07561983
- Conditions
- Chemoembolization, Therapeutic, Chemotherapy, Conversion Therapy, +2 more
- Locations
-
- Sichuan Cancer Hospital and Research Institute Chengdu, Sichuan, China
Not Yet Recruiting
Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2
NCT07531979
- Conditions
- Becotatug Vedotin, Chemotherapy, EGFR ADC, +3 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, China
Not Yet Recruiting
Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer
NCT06871527
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Fruquintinib, +11 more
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
Not Yet Recruiting
Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer
NCT05841134
- Conditions
- Capecitabine, MSI-H Colorectal Cancer, Oxaliplatin, +1 more
- Locations
-
Not specified
NCT05375734
- Conditions
- Immunotherapy, Pulmonary Pleomorphic Carcinoma, Tislelizumab
- Locations
-
- The Second Afiliated Hospital of Nanchang University Nanchang, Jiangxi, China
NCT06233981
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciecnces and Peking Union Medical College Beijing, China